Items

Fate of Bioresorbable Vascular Scaffold Metallic Radio-Opaque Markers at the Site of Implantation After Bioresorption (2015-06)

P. Suwannasom, Y. Onuma, C. Campos, S. Nakatani, Y. Ishibashi, H. Tateishi, M. Grundeken, B. Stanetić, K. Nieman, H. Jonker, H. Garcia-Garcia, P. Serruys, Fate of Bioresorbable Vascular Scaffold Metallic Radio-Opaque Markers at the Site of Implantation After Bioresorption, JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, Vol. 8, No. 8, pp. 1130 - 1132, Jun, 2015
Risk stratification in 3-vessel coronary artery disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II trial. (2015-11)

B. Stanetić, C. Campos, V. Farooq, S. Walsh, Y. Ishibashi, Y. Onuma, H. Garcia-Garcia, J. Escaned, A. Banning, P. Serruys, Risk stratification in 3-vessel coronary artery disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II trial., CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 15, No. 86, pp. 229 - 238, Nov, 2015
Appropriateness of myocardial revascularization assessed by the SYNTAX Score II in a country without cardiac surgery facilities. (2016-05)

B. Stanetić, C. Campos, v. Farooq, T. Kovačević-Preradović, K. Huber, M. Ostojić, P. Serruys, Appropriateness of myocardial revascularization assessed by the SYNTAX Score II in a country without cardiac surgery facilities., ČASOPIS UDRUŽENJA PULMOLOGA REPUBLIKE SRPSKE, pp. 75 - 84, May, 2016
Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease. (2016-06)

J. Escaned, A. Banning, V. Farooq, M. Echavarria-Pinto, Y. Onuma, N. Ryan, R. Calvacante, C. Campos, B. Stanetić, Y. Ishibashi, P. Suwannasom, A. Kappetein, D. Taggart, M. Morel, G. van Es, P. Serruys, Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease., EuroIntervention, Vol. 12, No. 2, pp. 224 - 234, Jun, 2016
ApPropriateness of myocaRdial RevascularizatiOn assessed by the SYNTAX score II in a coUntry without cardiac Surgery faciliTies; PROUST study. (2017-01)

BM. Stanetić, M. Ostojić, C. Campos, J. Marinkovic, V. Farooq, T. Kovačević-Preradović, K. Huber, P. Serruys, ApPropriateness of myocaRdial RevascularizatiOn assessed by the SYNTAX score II in a coUntry without cardiac Surgery faciliTies; PROUST study., INTERNATIONAL JOURNAL OF CARDIOLOGY, Vol. 227, pp. 478 - 484, Jan, 2017
aPProPriateness oF myoCardial revasCularization assessed By SYNTAX sCore II in a Centre without on-site CardiaC surgery. (2015)

B. Stanetić, M. Ostojić, K. Huber, C. Campos, T. Kovačević-Preradović, P. Serruys, aPProPriateness oF myoCardial revasCularization assessed By SYNTAX sCore II in a Centre without on-site CardiaC surgery., JACC Mart 17, 2015;65:10s, 2015
Appropriateness Of Myocardial Revascularization Assessed By Syntax Score II In A Centre Without On-Site Cardiac Surgery. (2015-03)

B. Stanetić, M. Ostojić, K. Huber, C. Campos, T. Kovačević-Preradović, P. Serruys, Appropriateness Of Myocardial Revascularization Assessed By Syntax Score II In A Centre Without On-Site Cardiac Surgery., Journal of American College of Cardiology., Mar, 2015
Natural history of coronary calcification: A 5-year serial optical coherence tomography study (2015-10)

M. Nato, C. Campos, H. Garcia-Garcia, B. Stanetić, S. Veldhof, P. Serruys, Natural history of coronary calcification: A 5-year serial optical coherence tomography study, Journal of American College of Cardiology, Oct, 2015
Risk Stratification in 3- Vessel Coronary Artery Disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II Trial. (2016)

C. Campos, B. Stanetić, V. Farooq, S. Walsh, Y. Ishibashi, Y. Onuma, H. Garcia-Garcia, J. Escaned, A. Banning, P. Serruys, Risk Stratification in 3- Vessel Coronary Artery Disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II Trial., 2016
Impact of diabetes mellitus on myocardial revascularisation method in the light of the 2018 ESC/EACTS guidelines: Results from the PROUST Study. (2019-09)

B. Stanetić, M. Ostojić, T. Kovačević-Preradović, L. Kos, A. Nikolić, M. Bojić, C. Campos, K. Huber, Impact of diabetes mellitus on myocardial revascularisation method in the light of the 2018 ESC/EACTS guidelines: Results from the PROUST Study., European Heart Journal Supplement, Sep, 2019

Items

Fate of Bioresorbable Vascular Scaffold Metallic Radio-Opaque Markers at the Site of Implantation After Bioresorption (2015-06)

Risk stratification in 3-vessel coronary artery disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II trial. (2015-11)

Appropriateness of myocardial revascularization assessed by the SYNTAX Score II in a country without cardiac surgery facilities. (2016-05)

Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease. (2016-06)

ApPropriateness of myocaRdial RevascularizatiOn assessed by the SYNTAX score II in a coUntry without cardiac Surgery faciliTies; PROUST study. (2017-01)

aPProPriateness oF myoCardial revasCularization assessed By SYNTAX sCore II in a Centre without on-site CardiaC surgery. (2015)

Appropriateness Of Myocardial Revascularization Assessed By Syntax Score II In A Centre Without On-Site Cardiac Surgery. (2015-03)

Natural history of coronary calcification: A 5-year serial optical coherence tomography study (2015-10)

Risk Stratification in 3- Vessel Coronary Artery Disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II Trial. (2016)

Impact of diabetes mellitus on myocardial revascularisation method in the light of the 2018 ESC/EACTS guidelines: Results from the PROUST Study. (2019-09)